Current Report Filing (8-k)

0001075415false00010754152022-11-022022-11-020001075415dhc:SeniorNotesDue2042Member2022-11-022022-11-020001075415dhc:SeniorNotesDue2046Member2022-11-022022-11-02

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC  20549

FORM 8-K 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): November 2, 2022

DIVERSIFIED HEALTHCARE TRUST

(Exact Name of Registrant as Specified in Its Charter)

 

Maryland

(State or Other Jurisdiction of Incorporation) 

001-15319						04-3445278
(Commission File Number)						(IRS Employer Identification No.)

Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458-1634

(Address of Principal Executive Offices) (Zip Code)

617-796-8350

(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title Of Each Class

Trading Symbol(s)

Name Of Each Exchange On Which Registered

Common Shares of Beneficial Interest

DHC

The Nasdaq Stock Market LLC

5.625% Senior Notes due 2042

DHCNI

The Nasdaq Stock Market LLC

6.25% Senior Notes due 2046

DHCNL

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

ITEM 2.02.  RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

 

On November 2, 2022, Diversified Healthcare Trust, or the Company, issued a press release regarding the Company’s results of operations and financial condition for the quarter and nine months ended September 30, 2022, and also provided certain supplemental operating and financial data for the quarter and nine months ended September 30, 2022. Copies of the Company’s press release and supplemental operating and financial data are furnished as Exhibits 99.1 and 99.2 hereto, respectively.

 

ITEM 9.01.  FINANCIAL STATEMENTS AND EXHIBITS.

 

(d)        Exhibits.

99.1			Press Release dated November 2, 2022
99.2			Third Quarter 2022 Supplemental Operating and Financial Data
104			Cover Page Interactive Data File. (Embedded within the Inline XBRL document.)

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

			DIVERSIFIED HEALTHCARE TRUST
			By:			/s/ Richard W. Siedel, Jr.
			Name:			Richard W. Siedel, Jr.
			Title:			Chief Financial Officer and Treasurer

 

Date:  November 2, 2022